• Policy
• 'BIO KOREA 2024' begins
• by Lee, Hye-Kyung May 10, 2024 05:47am

• Policy
• Celltrion Pharm completes localizing 3 Edarbi products
• by Lee, Hye-Kyung May 9, 2024 05:52am

• Policy
• Name of transferred and aquired drugs can be changed in KOR
• by Lee, Hye-Kyung May 9, 2024 05:52am

• Policy
• AZ renews orphan drug Strensiq’s risk-sharing agreement
• by Lee, Tak-Sun May 9, 2024 05:52am

• Policy
• MSD’s Cancidas will retain premium pricing for up to 5 yrs
• by Lee, Tak-Sun May 8, 2024 05:48am

• Policy
• Will oral anemia drugs for dialysis patients be reimbursed?
• by Lee, Tak-Sun May 7, 2024 05:50am

• Policy
• Handok’s imported PNH drug Empaveli is approved in Korea
• by Lee, Hye-Kyung May 3, 2024 05:53am

• Policy
• AZ wins nod for new breast cancer drug 'Tiroo Cap Tab'
• by Lee, Hye-Kyung May 3, 2024 05:53am

• Policy
• 1488 drugs approved last year…30% diabetes drugs
• by Lee, Hye-Kyung May 2, 2024 05:52am

• Policy
• 32 med schools in KOR confirm their admission quota
• by Lee, Jeong-Hwan May 2, 2024 05:52am